Table 1.
Biodegradable Materials | Fabrication Technique | Microcarrier Characteristics | Cell Type and Use Case | Reference |
---|---|---|---|---|
Cell expansion for therapy | ||||
PLGA + porcine gelatin coating | Emulsification of gelatin in PLGA/dichloromethane solution, followed by an emulsion-solvent evaporation method (25) | Porous 360 cm2/g d50 = 166 µm |
Human adipose stem cells | [34] |
PLGA + bovine gelatin or PLL coating | Single-emulsion solvent evaporation method followed by lyophilization | Porous d = 165–260 µm |
Human umbilical vein endothelial cells | [74] |
Gelatin | Droplet microfluidics (gelatin solution + fluorocarbon oil), followed by solidification in ice box | Non-porous d = 55–180 µm |
Human mesenchymal stem cells | [48] |
Cross-linking commercial gelatin beads (CultiSpher G) using 1,2-bis(2-isocyanatoethyl) disulfide | Porous (pore size: 5–15 µm) d = 130–380 µm (hydrated) |
Human mesenchymal stem cells | [72] | |
PEG/alginate + chitosan coating | Emulsification of sodium alginate and PEG (water phase) and Tween80/peanut oil (oil phase) peanut oil (oil phase) | Porous (pore size: 20–200 µm) d = 700–1900 µm |
Human umbilical cord blood mesenchymal stem cells | [38] |
Poly-e-caprolactone (PCL) + poly-l-lysine or fibronectin coating | Droplet microfluidics | Non-porous d = 150–170 µm |
Stem cell expansion (WJ-MSC, hESCs) Tissue engineering (in vivo osteogenic differentiation) |
[30,77,78,79] |
Chitosan | Micro-emulsification of chitosan solution in oil phase followed by low-temperature thermally induced phase separation technique | Porous (pore size: 20–50 µm) d = 150 µm | Cell expansion (human fetal hepatocytes) | [80,81] |
Zein | Zein ground in glycerin at 120 °C, 5 min, followed by the removal of glycerin by suction filtration. Finally, particles are repeatedly washed with pure water | Low porosity d = 150–230 µm 350 cm2/g 1.045 g/cm3 |
Cell expansion (vero cells) | [82] |
Cell expansion for tissue engineering | ||||
PLGA/hydroxyapatite + incorporated graphene | Emulsion-solvent evaporation, followed by surface immobilization of BMP-2 | Non-porous d50 = 520 µm |
Osteogenesis | [46,83] |
PLGA + poly-l-lysine coating | Emulsion-solvent evaporation method, followed by surface immobilization of BMP-7 and ponericin G1 | Non-porous d50 = 560 µm |
Osteogenesis | [83] |
Poly-lactic acid (PLA) + human recombinant collagen type I coating | Emulsion/solvent (ethyl-lactate) evaporation technique | Non-porous d = 82 ± 23 µm |
Rat bone marrow MSCs | [32] |
Cellulose/chitosan (cross-linked) | Water phase consisting of cellulose and chitosan solution emulsified into microspheres in liquid paraffin (oil phase) under stirring, followed by phase separation through liquid nitrogen quenching and petroleum ether | Porous (pore size: 30–60 µm) d = 450 um |
Bone marrow derived MSCs for cartilage regeneration | [72] |
Drug delivery | ||||
Tofu/soybean protein | Capillary microfluidic (emulsification) device, followed by thorough ethyl alcohol wash to get rid of soybean oil from the bead’s surface | Porous d = 640–740 µm |
Drug delivery | [61] |
Pectin | Electrospraying pectin solution into solution of cross-linking mixture (CaCl2/oligochitosan), followed by rinsing with DI water | Porous d = 150–600 µm |
Drug delivery | [47] |